Results

Total Results: 455 records

Showing results for "malignant neoplasm".

  1. www.uspreventiveservicestaskforce.org/uspstf/document/evidence-summary/breast-cancer-medications-for-risk-reduction-2002
    May 06, 2002 - Randomized trial of fenretinide to prevent second breast malignancy in women with early breast cancer … Contralateral primary tumors in breast cancer patients in a randomized trial of adjuvant tamoxifen therapy … Progesterone and estrogen receptors and mammary neoplasia in the Iowa Women's Health Study: how many … nodes and estrogen receptor-positive tumors. … Search Terms No. of Results 1 Explode breast neoplasms 90,662 2 Limit 1 to (human
  2. psnet.ahrq.gov/web-mm/critical-echocardiogram-result-lost-follow
    July 31, 2023 - to find that follow-up imaging was scheduled for 60% of the unexpected findings, of which potential neoplasms … finding did not need radiologic follow-up (e.g., small lung nodules in a patient at low risk of lung cancer … More Related Resources WebM&M Cases Delay in Malignancy … Safety Innovations Ambulatory Safety Nets to Reduce Missed and Delayed Diagnoses of Cancer
  3. hcup-us.ahrq.gov/reports/statbriefs/sb201-Mastectomies-Inpatient-Outpatient.jsp
    November 01, 2014 - Although 97-99 percent of breast cancers occur in only one breast, 1 some women choose also to remove … ; 2.9% were bilateral, no cancer; and 10.5% were bilateral, cancer. … for this Statistical Brief: V5041 (prophylactic breast removal) and V8401 (genetic susceptibility to malignantneoplasm of breast). … Hospital and Ambulatory Surgery Care for Women's Cancers. HCUP Highlight #2. AHRQ Pub. No. 06-0038.
  4. hcup-us.ahrq.gov/reports/statbriefs/sb201-Mastectomies-Inpatient-Outpatient.pdf
    November 01, 2014 - Although 97– 99 percent of breast cancers occur in only one breast,1 some women choose also to remove … Hospital and Ambulatory Surgery Care for Women’s Cancers. HCUP Highlight #2. AHRQ Pub. … Unilateral, cancer Bilateral, no cancer Bilateral, cancer 9 Data Source The volumes … for this Statistical Brief: V5041 (prophylactic breast removal) and V8401 (genetic susceptibility to malignantneoplasm of breast).
  5. www.uspreventiveservicestaskforce.org/uspstf/document/evidence-summary/colorectal-cancer-screening-june-2016
    June 15, 2016 - (n = 10,286), which had about 4 years of follow-up, 0.35% of examinations revealed an extracolonic malignancy … Screening for colorectal neoplasms with new fecal occult blood tests: update on performance characteristics … Association between early stage colon neoplasms and false-negative results from the fecal immunochemical … Accuracy of CT colonography for detection of large adenomas and cancers. … Extracolonic tumors of the gastrointestinal tract detected incidentally at screening CT colonography.
  6. www.ahrq.gov/sites/default/files/2024-03/gawande-report.pdf
    January 01, 2024 - identify the major adverse events in principle areas of neurosurgery (open cerebrovascular, endovascular, tumor … Patterns in neurosurgical adverse events: intracranial neoplasm surgery. … Patterns in neurosurgical adverse events: intracranial neoplasm surgery.
  7. www.uspreventiveservicestaskforce.org/home/getfilebytoken/-hnLT26c2NHs6thK9yznPF
    July 01, 2002 - (70 cancers) Chemoprevention of Breast Cancer 39 Chemoprevention of Breast Cancer 40 studies … Randomized trial of fenretinide to prevent second breast malignancy in women with early breast cancer … Progesterone and estrogen receptors and mammary neoplasia in the Iowa Women’s Health Study: how many … nodes and estrogen receptor-positive tumors. … 1 Explode breast neoplasms 90,662 2 Limit 1 to (human and female) 70,714 3 Explode Tamoxifen 6,743
  8. hcup-us.ahrq.gov/db/nation/nrd/NRD_Introduction_2013.jsp
    January 01, 2013 - comorbidity present, (0) comorbidity not present CM_TUMOR AHRQ comorbidity measure - Solid tumor … ; other and unspecified primary 1,514 16.84 17.90 6.3 42: Secondary malignancies 65,482 … 23.08 23.97 3.8 43: Malignant neoplasm without specification of site 2,667 24.03 … 24.82 3.3 44: Neoplasms of unspecified nature or uncertain behavior 14,836 25.74 26.54 … neoplasm of uterus 4,909 7.29 7.37 1.1 47: Other and unspecified benign neoplasm
  9. www.ahrq.gov/hai/pfp/haccost2017-results.html
    November 01, 2017 - pediatric patients, intensive care unit patients, and those with specific conditions (e.g., epilepsy, cancer … conducted among ICU patients with only three studying patients outside of these units, one looking at cancer … underwent an ablative procedure for a malignant oral cavity, laryngeal, hypopharyngeal, or oropharyngeal neoplasm … majority of studies in our analysis focused on specific patient subpopulations (e.g., trauma patients, cancer
  10. www.uspreventiveservicestaskforce.org/home/getfilebytoken/Xbtq4oDQwVo7KgmSjnnDbz
    November 01, 2021 - (n = 10 286), which had about 4 years of follow-up, 0.35% of examinations revealed an extracolonic malignancy … Screening for colorectal neoplasms with new fecal occult blood tests: update on performance characteristics … Association between early stage colon neoplasms and false-negative results from the fecal immunochemical … Accuracy of CT colonography for detection of large adenomas and cancers. … Extracolonic tumors of the gastrointestinal tract detected incidentally at screening CT colonography.
  11. hcup-us.ahrq.gov/db/nation/nrd/NRD_Introduction_2010-2014.jsp
    January 01, 2014 - comorbidity present, (0) comorbidity not present CM_TUMOR AHRQ comorbidity measure - Solid tumor … ; other and unspecified primary 1,514 16.84 17.90 6.3 42: Secondary malignancies 65,482 … 23.08 23.97 3.8 43: Malignant neoplasm without specification of site 2,667 24.03 … 24.82 3.3 44: Neoplasms of unspecified nature or uncertain behavior 14,836 25.74 26.54 … neoplasm of uterus 4,909 7.29 7.37 1.1 47: Other and unspecified benign neoplasm
  12. hcup-us.ahrq.gov/db/nation/nrd/Introduction_NRD_2013.pdf
    January 01, 2013 - Introduction Category Data Element Name Description CM_TUMOR AHRQ comorbidity measure - Solid tumor … 24: Cancer of breast 18,788 9.27 9.41 1.5 25: Cancer of uterus 10,304 11.81 12.35 4.5 26: Cancer … ; other and unspecified primary 1,514 16.84 17.90 6.3 42: Secondary malignancies 65,482 23.08 … 23.97 3.8 43: Malignant neoplasm without specification of site 2,667 24.03 24.82 3.3 44: Neoplasmsneoplasm of uterus 4,909 7.29 7.37 1.1 47: Other and unspecified benign neoplasm 34,259 12.74
  13. hcup-us.ahrq.gov/toolssoftware/ccs/AppendixASingleDX.txt
    January 01, 2024 - V1029 V1081 V1084 V1088 V1089 V109 V1090 V1091 V711 42 Secondary malignancies … 1983 1984 1985 1986 1987 19881 19882 19889 20971 20972 20973 20974 51181 78951 43 Malignant … 44 Neoplasms of unspecified nature or uncertain behavior 2350 2351 2352 2353 2354 2355 2356 2357 … chemotherapy; radiotherapy V580 V581 V5811 V5812 V661 V662 V671 V672 46 Benign … and unspecified benign neoplasm 20940 20941 20942 20943 20950 20951 20952 20953 20954 20955 20956
  14. effectivehealthcare.ahrq.gov/sites/default/files/related_files/liver-cancer_executive.pdf
    October 01, 2014 - Executive Summary Background and Objectives Hepatocellular carcinoma (HCC) is the most common primary malignantneoplasm of the liver, usually developing in individuals with chronic liver disease or cirrhosis. … Worldwide, it is the fifth most common cancer and the third most common cause of cancer death.1 There … National Cancer Institute. Liver Cancer. www.cancer.gov/ cancertopics/types/liver. … SEER Cancer Statistics Review, 1975-2010.
  15. hcup-us.ahrq.gov/db/nation/nrd/Introduction_NRD_2019.jsp
    January 01, 2019 - ; other and unspecified primary 1,514 16.84 17.90 6.3 42: Secondary malignancies 65,482 … 23.08 23.97 3.8 43: Malignant neoplasm without specification of site 2,667 24.03 … 24.82 3.3 44: Neoplasms of unspecified nature or uncertain behavior 14,836 25.74 26.54 … 3.1 45: Maintenance chemotherapy; radiotherapy 25,281 61.29 61.98 1.1 46: Benignneoplasm of uterus 4,909 7.29 7.37 1.1 47: Other and unspecified benign neoplasm
  16. effectivehealthcare.ahrq.gov/sites/default/files/pdf/pain-chronic_research-protocol.pdf
    July 28, 2010 - Brief Protocol Project Title: Technical Brief - Multidisciplinary Pain Programs for Chronic Non-Cancer … Background and Objectives for the Technical Brief Chronic non-cancer pain: Chronic pain symptoms … estimates that 9 percent of the United States adult population suffers from moderate to severe, non-cancer … Patients with cancer 2. … Published Online: July 28, 2010 12 21 "pain clinic".tw. 22 19 or 20 or 21 23 18 or 22 24 exp Neoplasms
  17. www.uspreventiveservicestaskforce.org/home/getfilebytoken/473PPVwoRhapCkN9SC-rue
    May 18, 2021 - small number of cancers detected in screening studies. … that are not the target of colorectal cancer screening (eg, carcinoid tumors). … Accuracy of CT colonography for detection of large adenomas and cancers. … Contributions of adenocarcinoma and carcinoid tumors to early-onset colorectal cancer incidence rates … Prevalence of advanced, precancerous colorectal neoplasms in black and white populations: a systematic
  18. hcup-us.ahrq.gov/db/nation/nrd/Introduction_NRD_2010-2014.pdf
    January 01, 2014 - Introduction Category Data Element Name Description CM_TUMOR AHRQ comorbidity measure - Solid tumor … 24: Cancer of breast 18,788 9.27 9.41 1.5 25: Cancer of uterus 10,304 11.81 12.35 4.5 26: Cancer … ; other and unspecified primary 1,514 16.84 17.90 6.3 42: Secondary malignancies 65,482 23.08 … 23.97 3.8 43: Malignant neoplasm without specification of site 2,667 24.03 24.82 3.3 44: Neoplasmsneoplasm of uterus 4,909 7.29 7.37 1.1 47: Other and unspecified benign neoplasm 34,259 12.74
  19. hcup-us.ahrq.gov/db/nation/nrd/Introduction_NRD_2020.pdf
    January 01, 2020 - 24: Cancer of breast 18,788 9.27 9.41 1.5 25: Cancer of uterus 10,304 11.81 12.35 4.5 26: Cancer … ; other and unspecified primary 1,514 16.84 17.90 6.3 42: Secondary malignancies 65,482 23.08 … 23.97 3.8 43: Malignant neoplasm without specification of site 2,667 24.03 24.82 3.3 44: Neoplasms … 14,836 25.74 26.54 3.1 45: Maintenance chemotherapy; radiotherapy 25,281 61.29 61.98 1.1 46: Benignneoplasm of uterus 4,909 7.29 7.37 1.1 47: Other and unspecified benign neoplasm 34,259 12.74
  20. hcup-us.ahrq.gov/db/nation/nrd/Introduction_NRD_2020.jsp
    January 01, 2020 - ; other and unspecified primary 1,514 16.84 17.90 6.3 42: Secondary malignancies 65,482 … 23.08 23.97 3.8 43: Malignant neoplasm without specification of site 2,667 24.03 … 24.82 3.3 44: Neoplasms of unspecified nature or uncertain behavior 14,836 25.74 26.54 … 3.1 45: Maintenance chemotherapy; radiotherapy 25,281 61.29 61.98 1.1 46: Benignneoplasm of uterus 4,909 7.29 7.37 1.1 47: Other and unspecified benign neoplasm

Search the AHRQ Archive

Information and reports more than 5 years old may be found in the AHRQ Archive site.

Search Archive